• English


Industry Symposium A

Thursday, 8 September 2022, 12:30- 13:30

Room Steiermark

Biofilm formation on implants: Current insights and latest advances



  • Introduction
  • Biofilm - Infection - Antibiotic resistance: The killing triad!
  • Alternative technologies to reduce the impact of the killing triad-Early clinical results
  • Discussion – Question and Answer session
  • End of the session


  • Prof. Peter Giannoudis Leeds Teaching Hospital Leeds, United Kingdom
  • Prof. Steffen Ruchholtz Universitätsklinik Giessen-Marburg Marburg, Germany

Industry Symposium B

Thursday, 8 September 2022, 17:35-18:35

Plenary Hall, Stefaniensaal


A multidisciplinary perspective on a new rapid syndromic multiplex-PCR assay and its theoritical clinical impacts


  • Biofire® joint infection panel pre-launch evaluation overview.
  • Time to pathogen identification - how does the biofire® joint infection panel compare with our standard methods?
  • How rapid syndromic testing impacts pji treatment? a case series to answer.



  • Stéphanie Pascual, Global Medical Affairs, bioMérieux, France
  • Dr. Catherine Aldridge, Microbiology Consultant, Newcastle Upon Tyne NHS, United Kingdom
  • Prof. Rihard Trebše, Orthopedic Surgeon, Valdoltra Orthopaedic Hospital, Slovenia

Industry Symposium C

Thursday, 8 September 2022, 17:35–18:35

Room: Saal Steiermark

Proof is in the pudding: Prosthetic Joint Infection Outcome with IV Fosfomycin from the PROOF-study


  • Introduction and Opening
  • Critical evaluation of current treatment strategies for prosthetic joint infections:

Standardized definition and diagnosis, surgical and antibiotic therapy in daily clinical practice

  • What can we learn from the PROOF-study?
  • Overall discussion and closing remarks



  • Andrej Trampuz Berlin, Germany
  • Olivier Borens Lausanne, Switzerland



Industry Symposium D

Friday, 9 September 2022, 12:35 – 13:35

Plenary Hall: Stefanien Saal

Team-based decision making in bone infections –

Delivering patient-friendly surgery with CERAMENT® G and CERAMENT® V



  • Welcome and introduction to the Oxford experience
  • 3 Case presentations
  • Panel discussion and questions from the audience
  • Summary and take-home messages



  • Prof. Martin McNally, Lead Consultant in Limb Reconstruction Surgery, Oxford Bone Infection Unit, Nuffield Orthopaedic Centre, UK
  • Mr. Jamie Ferguson, Consultant in Limb Reconstruction Surgery and Trauma, Oxford Bone Infection Unit and Oxford Trauma Unit, UK
  • Dr. Bridget Atkins, Consultant in Infectious Diseases and Microbiology, Oxford Bone Infection Unit, Nuffield Orthopaedic Centre, UK
  • Mr. Alex Ramsden, Consultant Plastic and Reconstructive Surgeon, Oxford Bone Infection Unit, Nuffield Orthopaedic Centre, UK


Case Presenters

  • Dr. Geertje Govaert, Consultant Trauma Surgeon, University Medical Centre Utrecht, Netherlands
  • Prof. Ricardo Sousa, Orthopaedics Department, Centro Hospitalar Universitário do Porto, Portugal
  • Mr. Adrian Kendal, Consultant in Foot & Ankle Surgery, Nuffield Orthopaedic Centre, Oxford, United Kingdom

Industry Symposium E

Friday, 9 September 2022, 12:35 – 13:35

Room: Saal Steiermark

BONE AND SOFT TISSUE INFECTIONS STIMULAN® - The importance of addressing infected saft tissue


  • Mr. Bilal Jamal, Consultant Orthopaedic Surgeon Glasgow, UK 
  • PD. Dr. Med. Yvonne Achermann, lnfectious Disease Specialist, Spital Zollikerberg, Switzerland
  • Dr. Bianca Price Technical & Clinical Research Manager Biocomposites, UK